Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer
03 Mar 2026
bởiStephen Padilla
Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.
Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer
03 Mar 2026
Better sleep yields greater weight loss for breast cancer survivors
02 Mar 2026
bởiStephen Padilla
Breast cancer survivors who have adequate sleep achieve greater benefits from behavioural weight loss (BWL) intervention than those with poor sleep, according to the results from the POWER-Remote trial.







